The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mongini, P. K.
Right arrow Articles by Inman, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mongini, P. K.
Right arrow Articles by Inman, J. K.

The Journal of Immunology, Vol 159, Issue 8 3782-3791, Copyright © 1997 by American Association of Immunologists

ARTICLES

The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2)

PK Mongini, MA Vilensky, PF Highet and JK Inman
Department of Rheumatology, Hospital for Joint Diseases, New York 10003, USA.

The present studies have examined whether the potential of an Ag to co- ligate the complement (C3d)-binding CD21 receptor complex with the membrane IgM (mIgM) receptor complex can reduce the mIgM:Ag affinity threshold for triggering human B cell S phase entry. A series of Ab:dextran conjugates consisting of affinity-diverse anti-IgM mAb, with and without anti-CD21 mAb, were synthesized as polyclonally reactive, moderately multivalent ligands that mimic C3d-bearing and non-C3d- bearing Ag. Co-ligation of mIgM and CD21 significantly diminished both the ligand concentration threshold and the IgM:ligand affinity threshold for eliciting S phase entry in the presence of IL-4. Furthermore, such co-engagement ablated the triggering bonus associated with high mlgM:ligand affinity, suggesting that B cells with a high affinity for Ag are not preferentially activated over B cells of intermediate affinity upon encountering a multivalent Ag with bound C3d. The enhancing effects of mIgM:CD21 co-ligation were restricted to low concentrations of ligand; at high concentrations, a decrease in B cell DNA synthesis was often observed. The findings suggest that the ability a moderately multivalent Ag substrate to engage B cells through both mIgM and CD21 is critical for B cell activation at limiting Ag concentrations, and furthermore, that mIgM:CD21 co-engagement may be particularly important in eliciting an immune response to such Ags in unprimed individuals in whom the majority of specific B cells are of low affinity.


This article has been cited by other articles:


Home page
 Int ImmunolHome page
A. Isaak, P. Gergely Jr, Z. Szekeres, J. Prechl, G. Poor, A. Erdei, and J. Gergely
Physiological up-regulation of inhibitory receptors Fc{gamma}RII and CR1 on memory B cells is lacking in SLE patients
Int. Immunol., February 1, 2008; 20(2): 185 - 192.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Lee, K. M. Haas, D. O. Gor, X. Ding, D. R. Karp, N. S. Greenspan, J. C. Poe, and T. F. Tedder
Complement Component C3d-Antigen Complexes Can Either Augment or Inhibit B Lymphocyte Activation and Humoral Immunity in Mice Depending on the Degree of CD21/CD19 Complex Engagement
J. Immunol., December 15, 2005; 175(12): 8011 - 8023.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. C. Baiu, B. Barger, M. Sandor, Z. Fabry, and M. N. Hart
Autoantibodies to Vascular Smooth Muscle Are Pathogenic for Vasculitis
Am. J. Pathol., June 1, 2005; 166(6): 1851 - 1860.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. T. Test, J. K. Mitsuyoshi, and Y. Hu
Depletion of Complement Has Distinct Effects on the Primary and Secondary Antibody Responses to a Conjugate of Pneumococcal Serotype 14 Capsular Polysaccharide and a T-Cell-Dependent Protein Carrier
Infect. Immun., January 1, 2005; 73(1): 277 - 286.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. C. Whipple, R. S. Shanahan, A. H. Ditto, R. P. Taylor, and M. A. Lindorfer
Analyses of the In Vivo Trafficking of Stoichiometric Doses of an Anti-Complement Receptor 1/2 Monoclonal Antibody Infused Intravenously in Mice
J. Immunol., August 15, 2004; 173(4): 2297 - 2306.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. H. J. Kim, I. D. Dimitriou, M. C. H. Holland, D. Mastellos, Y. M. Mueller, J. D. Altman, J. D. Lambris, and P. D. Katsikis
Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses
J. Immunol., August 15, 2004; 173(4): 2524 - 2529.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. F. Bower, X. Yang, J. Sodroski, and T. M. Ross
Elicitation of Neutralizing Antibodies with DNA Vaccines Expressing Soluble Stabilized Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Conjugated to C3d
J. Virol., May 1, 2004; 78(9): 4710 - 4719.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. K. A. Mongini, A. E. Jackson, S. Tolani, R. J. Fattah, and J. K. Inman
Role of Complement-Binding CD21/CD19/CD81 in Enhancing Human B Cell Protection from Fas-Mediated Apoptosis
J. Immunol., November 15, 2003; 171(10): 5244 - 5254.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. D. Green, D. C. Montefiori, and T. M. Ross
Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d
J. Virol., February 1, 2003; 77(3): 2046 - 2055.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
C. H. Nielsen and R. G. Q. Leslie
Complement's participation in acquired immunity
J. Leukoc. Biol., August 1, 2002; 72(2): 249 - 261.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Jozsi, J. Prechl, Z. Bajtay, and A. Erdei
Complement Receptor Type 1 (CD35) Mediates Inhibitory Signals in Human B Lymphocytes
J. Immunol., March 15, 2002; 168(6): 2782 - 2788.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. A. Vereshchagina, M. Tolnay, and G. C. Tsokos
Multiple Transcription Factors Regulate the Inducible Expression of the Human Complement Receptor 2 Promoter
J. Immunol., May 15, 2001; 166(10): 6156 - 6163.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. T. Test, J. Mitsuyoshi, C. C. Connolly, and A. H. Lucas
Increased Immunogenicity and Induction of Class Switching by Conjugation of Complement C3d to Pneumococcal Serotype 14 Capsular Polysaccharide
Infect. Immun., May 1, 2001; 69(5): 3031 - 3040.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. J. Strobl, H. Höfelmayr, G. Marschall, M. Brielmeier, G. W. Bornkamm, and U. Zimber-Strobl
Activated Notch1 Modulates Gene Expression in B Cells Similarly to Epstein-Barr Viral Nuclear Antigen 2
J. Virol., February 15, 2000; 74(4): 1727 - 1735.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
D. C. Baiu, J. Prechl, A. Tchorbanov, H. D. Molina, A. Erdei, A. Sulica, P. J. A. Capel, and W. L. W. Hazenbos
Modulation of the Humoral Immune Response by Antibody-Mediated Antigen Targeting to Complement Receptors and Fc Receptors
J. Immunol., March 15, 1999; 162(6): 3125 - 3130.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. K.A. Mongini, Q. Liu, M. A. Vilensky, P. F. Highet, and J. K. Inman
Evidence for an Upper Affinity Threshold for Anti-IgM-Induced Apoptosis in a Human B-Cell Lymphoma
Blood, November 15, 1998; 92(10): 3756 - 3771.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.